Header Logo

Parameswaran Venugopal

Concepts (236)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
19
2023
224
1.880
Why?
Lymphoma, Non-Hodgkin
8
2019
37
1.210
Why?
Leukemia, Myeloid, Acute
5
2021
49
1.200
Why?
Arabinonucleosides
4
2021
6
0.990
Why?
Lymphoma
3
2023
36
0.970
Why?
Antibodies, Monoclonal
8
2011
192
0.970
Why?
Lymphoma, Large B-Cell, Diffuse
6
2019
34
0.960
Why?
Central Nervous System Neoplasms
3
2023
9
0.960
Why?
Rituximab
16
2023
50
0.940
Why?
Antineoplastic Agents
5
2022
176
0.800
Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
29
0.770
Why?
Adenine Nucleotides
2
2010
2
0.700
Why?
Burkitt Lymphoma
3
2021
7
0.570
Why?
Paraproteinemias
2
2019
6
0.550
Why?
Insulin-Like Growth Factor Binding Proteins
1
2015
9
0.500
Why?
Middle Aged
25
2023
8509
0.480
Why?
Insulin-Like Growth Factor I
1
2015
52
0.470
Why?
Adult
21
2021
7364
0.460
Why?
Treatment Outcome
18
2021
3293
0.460
Why?
Humans
43
2023
26028
0.460
Why?
Aged
22
2023
8705
0.430
Why?
Male
25
2022
14011
0.410
Why?
Cyclophosphamide
9
2021
49
0.390
Why?
Necrobiotic Xanthogranuloma
1
2011
2
0.390
Why?
Plasma Cells
1
2011
5
0.390
Why?
Mediastinum
1
2011
7
0.390
Why?
Lymphoma, Mantle-Cell
1
2011
2
0.380
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
3
2022
15
0.360
Why?
Female
26
2021
14399
0.360
Why?
Doxorubicin
7
2021
54
0.350
Why?
Arsenicals
2
2007
11
0.340
Why?
Oxides
2
2007
15
0.340
Why?
Cranial Irradiation
2
2007
11
0.340
Why?
Aged, 80 and over
11
2023
4660
0.340
Why?
Vincristine
7
2019
21
0.330
Why?
Prednisone
7
2019
61
0.320
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
9
0.310
Why?
Cachexia
2
2019
13
0.300
Why?
Disease-Free Survival
7
2021
158
0.300
Why?
Kaplan-Meier Estimate
5
2021
161
0.290
Why?
Leukemia, Myelomonocytic, Acute
1
2007
1
0.290
Why?
Sarcoma, Myeloid
1
2007
4
0.280
Why?
Ear Neoplasms
1
2007
7
0.280
Why?
Lymphoproliferative Disorders
2
2023
14
0.280
Why?
Brain Neoplasms
2
2006
73
0.280
Why?
Recurrence
6
2020
306
0.270
Why?
Epstein-Barr Virus Infections
2
2023
11
0.270
Why?
HIV Infections
2
2021
463
0.260
Why?
Purpura, Thrombotic Thrombocytopenic
1
2006
10
0.260
Why?
Drug Administration Schedule
6
2019
156
0.260
Why?
Biomarkers
3
2019
549
0.240
Why?
Combined Modality Therapy
4
2019
277
0.240
Why?
Immunotherapy
2
2008
48
0.240
Why?
Prognosis
6
2021
750
0.240
Why?
Lymphomatoid Granulomatosis
1
2003
2
0.230
Why?
Lymphoma, B-Cell
3
2008
9
0.220
Why?
Proto-Oncogene Proteins c-myc
2
2021
15
0.210
Why?
Remission Induction
6
2015
88
0.200
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2011
10
0.190
Why?
Drug Resistance, Neoplasm
3
2020
61
0.180
Why?
Thrombosis
1
2021
51
0.180
Why?
Deubiquitinating Enzymes
1
2020
1
0.170
Why?
Benzylidene Compounds
1
2020
1
0.170
Why?
Azepines
1
2020
3
0.170
Why?
Retrospective Studies
5
2023
3299
0.170
Why?
Multiple Myeloma
1
2020
21
0.170
Why?
Young Adult
4
2021
1853
0.170
Why?
Folic Acid Deficiency
1
2019
5
0.170
Why?
Phthalazines
1
2019
5
0.170
Why?
Graft vs Host Disease
1
2020
51
0.160
Why?
Central Nervous System
3
2023
54
0.160
Why?
Respiratory Insufficiency
1
2020
49
0.160
Why?
Proportional Hazards Models
2
2017
326
0.160
Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
20
0.160
Why?
Hematopoietic Stem Cell Transplantation
1
2020
112
0.160
Why?
Piperazines
1
2019
76
0.160
Why?
Neutropenia
4
2012
16
0.150
Why?
Cytosine
2
2021
4
0.150
Why?
Neoplasm Recurrence, Local
3
2021
185
0.150
Why?
Kidney Diseases
1
2019
100
0.150
Why?
Medical Oncology
1
2018
40
0.150
Why?
Cardiology
1
2018
43
0.150
Why?
Immunity
1
2017
15
0.140
Why?
Bendamustine Hydrochloride
1
2016
8
0.140
Why?
Immunocompromised Host
1
2017
43
0.140
Why?
Stroke Volume
1
2016
55
0.140
Why?
Biopsy
2
2019
199
0.130
Why?
Registries
1
2017
171
0.130
Why?
Feasibility Studies
2
2019
202
0.130
Why?
Induction Chemotherapy
1
2015
13
0.120
Why?
Hematologic Neoplasms
1
2014
17
0.120
Why?
Myelodysplastic Syndromes
2
2004
32
0.110
Why?
Metabolic Syndrome
1
2014
55
0.110
Why?
Herpesvirus 4, Human
2
2023
8
0.110
Why?
Leukopenia
2
2011
6
0.110
Why?
Lymphoma, Follicular
2
2011
3
0.110
Why?
Methotrexate
2
2023
36
0.110
Why?
Transcription Factors
2
2004
159
0.110
Why?
Cytarabine
3
2023
11
0.100
Why?
Daunorubicin
2
2015
5
0.100
Why?
Hemoglobinuria, Paroxysmal
1
2012
2
0.100
Why?
Transcriptome
1
2012
80
0.100
Why?
DNA-Binding Proteins
2
2004
254
0.100
Why?
Diabetes Mellitus, Type 2
1
2014
173
0.100
Why?
Obesity
1
2014
277
0.100
Why?
Agranulocytosis
1
2011
3
0.100
Why?
Lymphoma, B-Cell, Marginal Zone
1
2011
6
0.100
Why?
Yttrium Radioisotopes
1
2011
9
0.090
Why?
Fatal Outcome
2
2008
50
0.090
Why?
Cytokines
1
2012
226
0.090
Why?
Retreatment
1
2010
8
0.090
Why?
Salvage Therapy
1
2010
36
0.090
Why?
Pilot Projects
1
2011
378
0.090
Why?
Platelet Count
2
2007
15
0.080
Why?
Infusions, Intravenous
2
2020
47
0.070
Why?
Tomography, X-Ray Computed
1
2011
713
0.070
Why?
Tretinoin
1
2007
14
0.070
Why?
Weight Loss
2
2019
120
0.070
Why?
Injections, Spinal
1
2007
32
0.070
Why?
Vascular Neoplasms
1
2006
4
0.070
Why?
Severity of Illness Index
2
2021
930
0.070
Why?
Follow-Up Studies
1
2011
1712
0.070
Why?
ADAMTS13 Protein
1
2006
5
0.070
Why?
Plasma Exchange
1
2006
10
0.070
Why?
ADAM Proteins
1
2006
39
0.060
Why?
Immunosuppressive Agents
2
2023
122
0.060
Why?
Autoantibodies
1
2006
71
0.060
Why?
Hemoglobins
1
2006
74
0.060
Why?
Survival Analysis
2
2019
235
0.060
Why?
Twins, Dizygotic
1
2005
3
0.060
Why?
United States
2
2021
1981
0.060
Why?
Radiography
1
2007
610
0.060
Why?
Cohort Studies
2
2021
1823
0.060
Why?
Kidney Transplantation
1
2006
120
0.060
Why?
Proto-Oncogenes
1
2004
4
0.060
Why?
Thalidomide
1
2004
6
0.060
Why?
Etoposide
2
2019
25
0.060
Why?
Peripheral Blood Stem Cell Transplantation
1
2004
1
0.060
Why?
Antigens, CD20
1
2003
4
0.060
Why?
Epilepsy, Tonic-Clonic
1
2003
5
0.060
Why?
Vision Disorders
1
2003
20
0.060
Why?
Antigens, Neoplasm
1
2003
38
0.060
Why?
Cyclin D1
1
2003
5
0.060
Why?
Cell Cycle Proteins
1
2003
13
0.050
Why?
K562 Cells
1
2003
3
0.050
Why?
Telomerase
1
2003
9
0.050
Why?
Histones
1
2003
24
0.050
Why?
Apoptosis
1
2003
193
0.050
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2022
1
0.050
Why?
Cerebral Cortex
1
2003
159
0.050
Why?
Voriconazole
1
2022
11
0.050
Why?
Sulfonamides
1
2022
37
0.050
Why?
Risk Factors
2
2005
2244
0.050
Why?
Azacitidine
1
2021
7
0.050
Why?
United Kingdom
1
2021
46
0.050
Why?
L-Lactate Dehydrogenase
1
2021
6
0.050
Why?
Gene Rearrangement
1
2021
9
0.050
Why?
Incidence
1
2023
713
0.040
Why?
Postoperative Complications
1
2006
862
0.040
Why?
Thrombocytopenia
2
2012
20
0.040
Why?
Activities of Daily Living
1
2023
522
0.040
Why?
Folic Acid
1
2019
13
0.040
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
2
0.040
Why?
Kidney Function Tests
1
2019
21
0.040
Why?
Maintenance Chemotherapy
1
2019
1
0.040
Why?
Translocation, Genetic
1
2019
5
0.040
Why?
Immunoglobulin A
1
2019
13
0.040
Why?
Maximum Tolerated Dose
1
2019
13
0.040
Why?
Symptom Assessment
1
2019
20
0.040
Why?
Anemia
2
2012
93
0.040
Why?
Transplantation, Homologous
1
2020
281
0.040
Why?
Vidarabine
2
2011
9
0.040
Why?
Body Composition
1
2019
61
0.040
Why?
Sarcopenia
1
2019
31
0.040
Why?
Lung Neoplasms
1
2003
505
0.040
Why?
Interdisciplinary Communication
1
2018
22
0.040
Why?
Ovarian Neoplasms
1
2019
66
0.040
Why?
Cardiologists
1
2018
7
0.040
Why?
Mitoxantrone
2
2011
4
0.040
Why?
Magnetic Resonance Imaging
1
2003
1140
0.040
Why?
Disease Management
1
2019
108
0.040
Why?
Bortezomib
1
2017
3
0.040
Why?
Sex Factors
1
2019
442
0.040
Why?
Tomography, Emission-Computed
2
2006
9
0.030
Why?
Prospective Studies
2
2015
1659
0.030
Why?
Disease Progression
2
2012
685
0.030
Why?
Neoplasms
1
2019
219
0.030
Why?
Recombinant Proteins
2
2008
200
0.030
Why?
Adolescent
1
2021
2064
0.030
Why?
Adenine
1
2015
1
0.030
Why?
Naphthalimides
1
2015
1
0.030
Why?
Organophosphonates
1
2015
1
0.030
Why?
Sensitivity and Specificity
2
2006
485
0.030
Why?
Lipid Metabolism
1
2014
27
0.030
Why?
Insulin Resistance
1
2014
45
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2004
119
0.030
Why?
Cytogenetic Analysis
1
2012
5
0.030
Why?
Signal Transduction
1
2014
389
0.030
Why?
RNA, Messenger
2
2003
264
0.030
Why?
Administration, Oral
1
2012
100
0.030
Why?
Pneumonia
1
2012
69
0.020
Why?
Radiopharmaceuticals
1
2011
49
0.020
Why?
Time Factors
1
2015
1365
0.020
Why?
Nausea
1
2007
23
0.020
Why?
Methylprednisolone
1
2007
20
0.020
Why?
Creatinine
1
2007
45
0.020
Why?
Animals
1
2014
3390
0.020
Why?
Cisplatin
1
2007
47
0.020
Why?
Dose-Response Relationship, Drug
1
2006
315
0.020
Why?
MDS1 and EVI1 Complex Locus Protein
1
2004
3
0.010
Why?
Zinc Fingers
1
2004
12
0.010
Why?
Cell Lineage
1
2004
22
0.010
Why?
Spleen
1
2004
31
0.010
Why?
Teniposide
1
2004
1
0.010
Why?
Bleomycin
1
2004
2
0.010
Why?
Neoplasm Staging
1
2005
313
0.010
Why?
Interferon-alpha
1
2004
30
0.010
Why?
Drug Therapy, Combination
1
2004
170
0.010
Why?
Patient Selection
1
2005
193
0.010
Why?
Transplantation, Autologous
1
2004
158
0.010
Why?
S Phase
1
2003
8
0.010
Why?
E2F Transcription Factors
1
2003
5
0.010
Why?
E2F1 Transcription Factor
1
2003
5
0.010
Why?
Retinoblastoma Protein
1
2003
10
0.010
Why?
Karyotyping
1
2003
8
0.010
Why?
Granulocytes
1
2003
15
0.010
Why?
In Situ Hybridization, Fluorescence
1
2003
29
0.010
Why?
DNA Primers
1
2003
45
0.010
Why?
Bone Marrow Cells
1
2003
50
0.010
Why?
Cell Nucleus
1
2003
71
0.010
Why?
Blotting, Western
1
2003
133
0.010
Why?
Transcription, Genetic
1
2003
91
0.010
Why?
Polymerase Chain Reaction
1
2003
104
0.010
Why?
Bone Marrow
1
2003
79
0.010
Why?
Acute Disease
1
2003
189
0.010
Why?
Immunohistochemistry
1
2003
335
0.010
Why?
Venugopal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (236)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_